X0306 4 2015-01-29 0 0001182129 AUXILIUM PHARMACEUTICALS INC AUXL 0001236927 FRIEDMAN PAUL A C/O AUXILIUM PHARMACEUTICALS, INC. 640 LEE ROAD CHESTERBROOK PA 19087 1 0 0 0 Common Stock 2015-01-29 4 J 0 5361 0.00 D 5000 D Common Stock 2015-01-29 4 J 0 5000 36.53 D 0 D Nonqualified Stock Option (Right to Buy) 29.72 2015-01-29 4 J 0 15000 36.53 D 2011-06-16 2020-06-02 Common Stock 15000 0 D Nonqualified Stock Option (Right to Buy) 24.62 2015-01-29 4 J 0 5000 36.53 D 2013-05-01 2022-06-20 Common Stock 5000 0 D Nonqualified Stock Option (Right to Buy) 20.44 2015-01-29 4 J 0 5000 36.53 D 2015-05-21 2024-05-20 Common Stock 5000 0 D In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these shares were exchanged for consideration comprised of a mix of cash and shares of Endo International plc, as determined pursuant to the Merger Agreement. In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these unvested shares of restricted stock were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement. In accordance with the provisions of the Amended and Restated Agreement and Plan of Merger, dated as of November 17, 2014 (the "Merger Agreement"), among Auxilium Pharmaceuticals, Inc., Endo International plc, Endo U.S. Inc., and Avalon Merger Sub Inc., as of the effective time of the closing of the merger on January 29, 2015, these options were cancelled in exchange for a cash payment determined pursuant to the Merger Agreement. /s/ Michael J. Purvis, as attorney-in-fact on behalf of Paul A. Friedman, M.D. 2015-01-30